TwoFour Insight (@TwoFourInsight) header
TwoFour Insight (@TwoFourInsight) profile picture

Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets ≠ endorsement

Pitt | WashDC | New Delhi
Joined January 2014
Allergan ($AGN) & Pfizer ($PFE) Notify Merger Details to Competition Commission of #India … buff.ly/1OlnMlX
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation ($GILD) #India #pharma buff.ly/1OH7GgF
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1JosuIi
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1Josic2
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation ($GILD) #India #pharma buff.ly/1Yx2EIR
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1OGeZW3
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1S4O1Nc
Generic Harvoni (Ledipasvir and Sofosbuvir) Indian Market Formation - TwoFour Insight Group buff.ly/1Yx1jSo
Indian Government Imposes Anti-Dumping Duty on Bulk Drug Imports of Gliclazide from China -… buff.ly/1YrqMSF
Pfizer Reaches Trademark Settlement with Cadila on Viagra in India - TwoFour Insight Group buff.ly/1RAkviZ
TwoFour Today's Weekly Recap - Trademark Litigation, Anti-Dumping Duty, Foreign Acquisition… buff.ly/1Mm25uB
Insight on India - India’s New Draft Patent Rules Feed into Modi’s Make in India Ambitions … buff.ly/1Mm0hBM
Pfizer Reaches Trademark Settlement with Cadila on Viagra in #India #pharma $PFE buff.ly/1MlXAQD
#India's FIPB Approves GMS #Pharma Investment in Strides Arcolab’s #Biotech Business buff.ly/1RrNNAk